Campus News

February 19, 2010
UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the American Journal of Transplantation that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.
February 19, 2010
People with symptoms of depression in middle age have a significantly greater risk in old age of being physically disabled or unable to carry out tasks of daily living, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
February 19, 2010
A UCSF group recommends that egg and sperm donors for in-vitro fertilization be provided information on possible use of embryos in stem cell research.
February 19, 2010
UCSF Chancellor Sue Desmond-Hellmann told House Speaker Nancy Pelosi federal economic stimulus funds will help University scientists conduct “biomedical research that literally will change the world.”
February 18, 2010
UCSF has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
February 18, 2010
Two UCSF scientists have been selected for the prestigious Potamkin Prize for their “outstanding achievements” in dementia research.
February 18, 2010
A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.
February 18, 2010
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.
February 17, 2010
UCSF Chancellor Sue Desmond-Hellmann today released a video message to the campus community explaining the need to focus on the University’s advancing health worldwide mission™ to adjust to new fiscal realities.
February 17, 2010
Message to the Campus By Chancellor Susan Desmond-Hellmann, MD, MPH February 17, 2010 I appreciate the opportunity to speak to all of you today – and I’m sorry that I’m doing it by videotape – but I wanted to communicate broadly across the campus and in a timely manner.  Our topic for today is the budget for next year, UCSF 2011, who we will be in the fiscal years 2011 and 2012.  I want to talk to you today about the situation, what you’ll see from me and my team, and what you can expect from me.

Pages